In the future, patients who suffer a relapse of the deadliest form of brain cancer may get a second shot at life with the help of a novel gene therapy developed by researchers from the National University of Singapore's Yong Loo Lin School of Medicine (NUS Medicine).
The scientists behind the stem cell-based gene therapy are aiming to start a clinical trial for glioblastoma patients of National University Hospital (NUH) by late 2025.
Glioblastoma is an incurable and aggressive brain tumour. Once diagnosed, patients are typically left with about two years to live.
This targeted therapy - designed to kill aggressive tumours and activate anti-cancer immunity builds on a similar drug that the NUS Medicine scientists first used to treat dogs and cats with terminal cancers.
A vial of the treatment comprises human stem cells carrying cancerkilling genes that naturally gravitate towards tumours.
The team from NUS Medicine's biochemistry department includes Associate Professor Too HengPhon, adjunct senior research fellow Sarah Ho and postdoctoral fellow Woo Jun Yung.
Prof Too's team initially worked on the therapy to combat aggressive human tumours until a vet who heard about it contacted them in 2018.
The first version of the treatment was used on 65 dogs and cats between 2018 and 2022. It had two parts first, the modified stem cells were injected into the animal, and then off-the-shelf anti-fungal drugs were taken orally.
The researchers developed a technology to insert large amounts of yeast-based genes into the stem cells that would react with the antifungal drugs.
This reaction would allow the cells to produce a chemotherapy drug called fluorouracil (5FU).
The modified stem cells act like suicide bombers, loading the toxic 5FU around the tumour to kill it, said Dr Ho.
この記事は The Straits Times の July 09, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は The Straits Times の July 09, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Krupnova brings positivity to Wondersticks and S'pore
While it has been only two weeks since Eliska Krupnova joined Singapore Floorball Premier League (SFL) side Wondersticks, the 2020 world's best female floorball player has lit up the league in more ways than one.
HER UNFINISHED BUSINESS
Belarusian Goutseva back to complete her artistic swimming vision for Singapore
Villa now in the big leagues, thanks to their manager
On The Ball | There are doubts about the new Champions League format, its extended group stage and \"Swiss model\" fixture list. Try telling that to anyone connected with Aston Villa, though.
REDS' WIN 'SPECIAL' FOR SLOT
Manager says it will let wife see a happy man, but warns of tough stretch ahead
Respectful Emery wary of United's winning mentality
Unai Emery praised the under-pressure Erik ten Hag on Oct 4 as the Aston Villa boss labelled Manchester United \"the best team in the world\" despite their dismal form.
ANGE FACES A 'CURIOUS' TEST BY HURZELER
Brighton boss, who asked 'many questions' on a day at Spurs in 2023, has 'inside info'
Pogba's 'nightmare is over' as ban cut to 18 months
French international footballer Paul Pogba said on Oct 4 that his \"nightmare is over\" after a four-year ban for doping was reduced to 18 months.
Blues need time to compete with City, Arsenal
Chelsea are improving but are not yet ready to compete with top English Premier League clubs like Manchester City and Arsenal, manager Enzo Maresca said on Oct 4.
Billie Jean King Cup to align with Davis Cup format
The Billie Jean King Cup Finals will transition to an eight-team event in 2025, from the current 12, to mirror the existing Davis Cup format, the International Tennis Federation (ITF) said on Oct 4.
Money talks to grow US rugby reportedly back on
Rugby union's governing body World Rugby has revived talks to raise funds for growing the sport in the United States, three people familiar with the matter said.